Evidence map›Paper›PMID 41256808›Full record

ArticleInternational journal of general medicine2025

Construction and Evaluation of a Prediction Model for Neonatal Hyperbilirubinemia.

Shasha Xu, Xiaoheng Guo, Cuiyan Li, Jing Chen, Changgeng Zhang

Abstract read
In one paragraph

Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shasha XuClinical Laboratory, Hengshui People's Hospital, Hengshui, Hebei, 053000, People's Republic of China.
Xiaoheng GuoClinical Laboratory, Hengshui People's Hospital, Hengshui, Hebei, 053000, People's Republic of China.
Cuiyan LiClinical Laboratory, Hengshui People's Hospital, Hengshui, Hebei, 053000, People's Republic of China.
Jing ChenObstetrics Department, Hengshui People's Hospital, Hengshui, Hebei, 053000, People's Republic of China.
Changgeng ZhangClinical Laboratory, Hengshui People's Hospital, Hengshui, Hebei, 053000, People's Republic of China.ORCID 0009-0002-8483-0759

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the factors that contribute to neonatal hyperbilirubinemia (NHB), develop a prediction model and predictive factors, which provide reference base for the early detection of NHB. Methods: A retrospective study was done to collect clinical data of 683 neonates and their mothers which delivered in the hospital's obstetrics department between January 2019 and January 2023, of these neonates 216 were hyperbilirubinemic and 467 were not. Clinical data and laboratory results of newborns and their mothers were collected and analysed. Multifactorial logistic regression analysis was utilised to develop an early prediction model and identify determinants of newborn hyperbilirubinemia. Results: The logistic regression model revealed that Delayed meconium (OR=4.024, P=0.002), maternal age (OR=1.106, P<0.01), maternal-infant blood group incompatibility (OR=4.457, P=0.001), Gestational Diabetes Mellitus (GDM) (OR=5.356, P=0.03), Pre-pregnancy co-morbidity (OR=2.810, <0.01), and Weight Growth Rate (WGR) during pregnancy (OR=28.367, P=0.048) were independent risk factors for NHB; 25-(OH)D3 (OR=0.880, P=0.002). The Conjoint predictor ROC curve is below 0.851 (P<0.01, 95% CI:0.821-0.882). The highest Youden's index was 0.55, with a sensitivity of 0.81 and a specificity of 0.76, indicating that the predictor had a decent predictive effect. Conclusion: This study identified the risk factors and protective factors associated with NHB. Additionally, a joint prediction model was developed to more accurately predict the risk of hyperbilirubinemia which can serve as a foundation for the clinical identification of pertinent susceptibility factors and the development of intervention measures.

Indexed as

25-(OH) D3GDMneonatal hyperbilirubinemiaprediction modelweight growth rate

Identifiers

PMID41256808
PMCPMC12622398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.